Literature DB >> 26866527

SHORT-TERM EFFECT OF INTRAVITREAL RANIBIZUMAB THERAPY ON MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION.

Yoshiro Minami1, Taiji Nagaoka, Akihiro Ishibazawa, Akitoshi Yoshida.   

Abstract

PURPOSE: To assess the short-term effect of intravitreal ranibizumab (IVR) on macular edema after branch retinal vein occlusion.
METHODS: Twenty-three eyes with macular edema after branch retinal vein occlusion were enrolled in a prospective observational study. After administering one IVR injection (0.5 mg) for the first time, the authors measured the foveal thickness (FT) before and 2 hours, 1 and 3 days, 1 week, and 1 month later and the best-corrected visual acuity at all times except 2 hours, and determined the changes from baseline (ΔFT and ΔVA).
RESULTS: The mean FT decreased significantly (P < 0.0001) from 522 ± 131 μm to 458 ± 96 μm after 2 hours. The mean logarithm of the minimum angle of resolution (logMAR) visual acuity improved significantly (P < 0.05) after 1 day from 0.69 ± 0.40 to 0.55 ± 0.34 (20/98-20/70, Snellen equivalent). The ΔFT after 2 hours was significantly positively correlated with the ΔFT after 1 week (r = 0.76, P < 0.001) and 1 month (r = 0.67, P < 0.001). The ΔVA after 1 day was correlated positively with the ΔVA after 1 week (r = 0.80, P < 0.001) and 1 month (r = 0.59, P < 0.01).
CONCLUSION: Structural and functional effects of IVR for branch retinal vein occlusion occurred within 1 day. The short-term effects of IVR may predict the outcome of the therapy at 1 week and 1 month after IVR in macular edema secondary to branch retinal vein occlusion.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26866527     DOI: 10.1097/IAE.0000000000000991

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  4 in total

1.  Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data.

Authors:  Focke Ziemssen; Patricio G Schlottman; Jennifer I Lim; Hansjürgen Agostini; Gabriele E Lang; Francesco Bandello
Journal:  Int J Retina Vitreous       Date:  2016-07-11

2.  Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.

Authors:  Yoshiro Minami; Taiji Nagaoka; Akihiro Ishibazawa; Akitoshi Yoshida
Journal:  BMC Ophthalmol       Date:  2017-06-13       Impact factor: 2.209

3.  Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.

Authors:  Yoshiro Minami; Taiji Nagaoka; Akihiro Ishibazawa; Akitoshi Yoshida
Journal:  BMC Ophthalmol       Date:  2017-03-14       Impact factor: 2.209

4.  Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion.

Authors:  Jing Wang; Ying Li; Shu-Fen Fang; Hong Wang
Journal:  BMC Ophthalmol       Date:  2020-07-09       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.